臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"ann lii cheng"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 186-235 / 690 (共14頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-09-01T02:02:09Z	Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; ANN-LII CHENG; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2021-09-01T02:02:08Z	Clinical studies with curcumin	Hsu C.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:08Z	Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma	Lu Y.-S.; Kashida Y.; Kulp S.K.; Wang Y.-C.; Wang D.; Hung J.-H.; Tang M.; Lin Z.-Z.; Chen T.-J.; ANN-LII CHENG; Chen C.-S.
臺大學術典藏	2021-09-01T02:02:08Z	A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer	Lin C.-C.; ANN-LII CHENG; Hsu C.-H.; Lu Y.-S.; Hsu C.; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H.
臺大學術典藏	2021-09-01T02:02:07Z	Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells	Chia H.C.; Chen P.-J.; Lee P.-H.; ANN-LII CHENG; Hsu H.-C.; Cheng J.C.-H.
臺大學術典藏	2021-09-01T02:02:07Z	Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial	Lin C.-C.; Hsu C.; Hsu C.-H.; Hsu W.-L.; ANN-LII CHENG; Yang C.-H.
臺大學術典藏	2021-09-01T02:02:07Z	Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - Significance of tumour cell clonality and BCL10 expression	Kuo S.-H.; Chen L.-T.; Wu M.-S.; Kuo K.-T.; Yeh K.-H.; Doong S.-L.; Yeh P.-Y.; Hsu H.-C.; Tzeng Y.-S.; Lin C.-W.; Lin J.-T.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:06Z	A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma	Chen Y.-M.; Yu C.-J.; Yang C.-H.; Perng R.-P.; Tsai C.-M.; Shih J.-F.; ANN-LII CHENG; Lefresne F.; Barbier M.; Pouget J.-C.; Yang P.-C.
臺大學術典藏	2021-09-01T02:02:06Z	Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏	2021-09-01T01:54:33Z	Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏	2021-09-01T01:54:32Z	Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma	Lin C.-C.; Yeh K.-H.; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-09-01T01:54:32Z	Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial	Lin C.-C.; Hsu C.-H.; Hour T.-C.; ANN-LII CHENG; Huang C.-Y.; Huang K.-H.; Chen J.; Pu Y.-S.
臺大學術典藏	2021-09-01T01:54:32Z	Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL	Lay J.-D.; Hong C.-C.; Huang J.-S.; Yang Y.-Y.; Pao C.-Y.; Liu C.-H.; Lai Y.-P.; Lai G.-M.; ANN-LII CHENG; Su I.-J.; Chuang S.-E.
臺大學術典藏	2021-09-01T01:54:31Z	Organization-based performance measures of cancer care quality: Core measure development for breast cancer in Taiwan	Chung K.-P.; Lai M.-S.; Cheng S.H.; Tang S.-T.; Huang C.C.; ANN-LII CHENG; Hsieh P.-C.
臺大學術典藏	2021-09-01T01:54:31Z	Molecular targeted therapy for advanced hepatocellular carcinoma	Shen Y.C.; Hsu C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:31Z	Epidemiology of multiple myeloma in Taiwan: Increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years	Huang S.-Y.; Yao M.; Tang J.-L.; Lee W.-C.; Tsay W.; ANN-LII CHENG; Wang C.-H.; Chen Y.-C.; Shen M.-C.; Tien H.-F.
臺大學術典藏	2021-09-01T01:54:30Z	Differential expression of glucocorticoid receptor in carcinomas of the human digestive system	Lien H.-C.; Lu Y.-S.; Shun C.-T.; Yao Y.-T.; Chang W.-C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:30Z	Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: Need for a revisit of surgical treatment	Kuo S.-H.; Chen L.-T.; Wu M.-S.; Lin C.-W.; Yeh K.-H.; Kuo K.-T.; Yeh P.-Y.; Tzeng Y.-S.; Wang H.-P.; Hsu P.-N.; Lin J.-T.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:30Z	A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial	Hsu C.; Hsiung C.A.; Su I.-J.; Hwang W.-S.; Wang M.-C.; Lin S.-F.; Lin T.-H.; Hsiao H.-H.; Young J.-H.; Chang M.-C.; Liao Y.-M.; Li C.-C.; Wu H.-B.; Tien H.-F.; Chao T.-Y.; Liu T.-W.; ANN-LII CHENG; Chen P.-J.
臺大學術典藏	2021-09-01T01:54:30Z	Prognostic factors in extrapulmonary small cell carcinomas: A large retrospective study	Lin Y.-L.; Chung C.-Y.; Chang C.-S.; Wu J.-S.; Kuo K.-T.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:29Z	Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment	Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; ANN-LII CHENG; Yang P.-C.; Yang C.-H.
臺大學術典藏	2021-09-01T01:54:29Z	Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation	Huang T.-C.; Yeh K.-H.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-09-01T01:54:29Z	FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C δ signaling	Hung J.-H.; Lu Y.-S.; Wang Y.-C.; Ma Y.-H.; Wang D.-S.; Kulp S.K.; Muthusamy N.; Byrd J.C.; ANN-LII CHENG; Chen C.-S.
臺大學術典藏	2021-09-01T01:54:28Z	Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia	Hong C.-C.; Lay J.-D.; Huang J.-S.; ANN-LII CHENG; Tang J.-L.; Lin M.-T.; Lai G.-M.; Chuang S.-E.
臺大學術典藏	2021-09-01T01:54:28Z	Sorafenib benefits Asian patients with advanced HCC	ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:28Z	Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells	Chen K.-F.; Yeh P.-Y.; Yeh K.-H.; Lu Y.-S.; Huang S.-Y.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:28Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; ANN-LII CHENG; Pao W.; Yang P.-C.
臺大學術典藏	2021-09-01T01:54:27Z	Overexpression of B cell activating factor of TNF family (BAFF) is associated with Helicobacter pylori independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma	Kuo S.-H.; Yeh P.-Y.; Chen L.-T.; Wu M.-S.; Lin C.-W.; Yeh K.-H.; Tzeng Y.-S.; Chen J.-Y.; Hsu P.-N.; Lin J.-T.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:27Z	NF-κB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells	Gao M.; Yeh P.Y.; Lu Y.-S.; Chang W.C.; Kuo M.-L.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:27Z	Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma	Lin C.-C.; Pu Y.-S.; Hsu C.-H.; Keng H.-Y.; ANN-LII CHENG; Yang C.-H.
臺大學術典藏	2021-09-01T01:54:26Z	Comprehensive Locoregional Treatment and Systemic Therapy for Postmastectomy Isolated Locoregional Recurrence	Kuo S.-H.; Huang C.-S.; Kuo W.-H.; ANN-LII CHENG; Chang K.-J.; Chia-Hsien Cheng J.
臺大學術典藏	2021-09-01T01:54:26Z	OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma	Gao M.; Yeh P.Y.; Lu Y.-S.; Hsu C.-H.; Chen K.-F.; Lee W.-C.; Feng W.-C.; Chen C.-S.; Kuo M.-L.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:26Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Hsu C.; Kuo S.-H.; Hu F.-C.; ANN-LII CHENG; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2021-09-01T01:54:25Z	Disseminated peritoneal leiomyomatosis responds to systemic chemotherapy	Lin Y.-C.; Wei L.-H.; Shun C.-T.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-09-01T01:54:25Z	Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathway	Dai H.-Y.; Hong C.-C.; Liang S.-C.; Yan M.-D.; Lai G.-M.; ANN-LII CHENG; Chuang S.-E.
臺大學術典藏	2021-09-01T01:54:25Z	Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells	Lin H.-J.L.; Zuo T.; Lin C.-H.; Chieh T.K.; Liyanarachchi S.; Sun S.; Shen R.; Deatherage D.E.; Potter D.; Asamoto L.; Lin S.; Yan P.S.; ANN-LII CHENG; Ostrowski M.C.; Huang T.H.-M.
臺大學術典藏	2021-09-01T01:54:24Z	Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy	Hsu C.; Wei S.-C.; ANN-LII CHENG; Chen P.-J.
臺大學術典藏	2021-09-01T01:54:24Z	National Center of Excellence for Clinical Trials and Research at National Taiwan University Hospital	Lin C.-C.; Yang C.-H.; ANN-LII CHENG; Chan W.-K.; Ho N.-N.
臺大學術典藏	2021-09-01T01:54:24Z	Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial	ANN-LII CHENG; Kang Y.-K.; Chen Z.; Tsao C.-J.; Qin S.; Kim J.S.; Luo R.; Feng J.; Ye S.; Yang T.-S.; Xu J.; Sun Y.; Liang H.; Liu J.; Wang J.; Tak W.Y.; Pan H.; Burock K.; Zou J.; Voliotis D.; Guan Z.
臺大學術典藏	2021-09-01T01:54:23Z	The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma	Lin Z.-Z.; Hsu H.-C.; Hsu C.-H.; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; Kuo S.-H.; Hsu C.; Hu F.-C.; Jeng Y.-M.; Chung Y.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:23Z	Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival	Shen Y.-C.; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; Lin Z.-Z.; Chang M.-C.; Hsu C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:23Z	Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: The molecular mechanism and the clinical application	Lee J.-H.; ANN-LII CHENG; Lin C.-W.; Kuo S.-H.
臺大學術典藏	2021-09-01T01:54:22Z	Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment	Shao Y.-Y.; Lin Z.-Z.; Liang P.-C.; Tien Y.-W.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:22Z	Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway	Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:21Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; ANN-LII CHENG; Yang P.-C.
臺大學術典藏	2021-09-01T01:54:21Z	Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - Analysis of 2010 Taiwanese patients	Chen C.-H.; Hu F.-C.; Huang G.-T.; Lee P.-H.; Tsang Y.-M.; ANN-LII CHENG; Chen D.-S.; Wang J.-D.; Sheu J.-C.
臺大學術典藏	2021-09-01T01:54:21Z	Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia	Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:20Z	Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study	Faivre S.; Raymond E.; Boucher E.; Douillard J.; Lim H.Y.; Kim J.S.; Zappa M.; Lanzalone S.; Lin X.; DePrimo S.; Harmon C.; Ruiz-Garcia A.; Lechuga M.J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:20Z	Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma	Yang S.-H.; Lin Z.-Z.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:20Z	Lamivudine and hepatitis B reactivation	Hsu C.; ANN-LII CHENG; Chen P.-J.

顯示項目 186-235 / 690 (共14頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51192496 線上人數 : 734 教育部委託研究計畫計畫執行:國立臺灣大學圖書館